Table: begin end state 1 15 cytoplasmic 16 40 transmembrane 41 44 non-cytoplasmic 45 73 transmembrane 74 110 cytoplasmic 111 134 transmembrane 135 140 non-cytoplasmic 141 163 transmembrane 164 171 cytoplasmic 172 189 transmembrane 190 205 non-cytoplasmic 206 225 transmembrane 226 258 cytoplasmic 259 281 transmembrane 282 320 non-cytoplasmic 321 344 transmembrane 345 355 cytoplasmic 356 380 transmembrane 381 389 non-cytoplasmic 390 408 transmembrane 409 414 cytoplasmic 415 444 transmembrane 445 464 non-cytoplasmic 465 489 transmembrane 490 508 cytoplasmic
Input: >GFF2715 METLGFLMDGFAVALTPYNLMFALFGAFVGTLIGCLPGLGPANGVAILIPLAFTLGLPPE TAMILLTAVYAGAMYGGRISSILLNIPGDEPAMMTCLDGYPMAQKGRAADALAVSAIASF AGGLIGTIGLIMLAPVLAKFALTFGPAEYFALFLLAFATLGGITGKNPVKTVVAATLGIM ISTVGIDISTGTQRYTFGVLELYEGIDFILAIVGLFAISELLFFVESRMGRGRDKMNVGK LTLTMKELVMTIPTQLRGGVLGFISGVLPGAGASLGSFISYTLEKQVVGKKGKFGEGDIR GVVAPEAGNNGASSGALVPMLTLGVPGSGTTAVLLAMLISLNITPGPLMFTQNADIVWGV IAALLIGNVLLLVLNIPLVGFFVKLLSVPPMYLLPIVTMVAFVGIYSISHSTFDLYFMVA FGVAGYFLRKLEIPLVPIILGLLLGPEMEKNLGHALVLSDGEWSVLWASPLAMGLWIVAG LGLILPYLVGPLLRRRMNAAMKESPVSD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server